Voythos
Voythos is a physician-founded bioinformatics startup developing multimodal artificial intelligence models to transform the management of aortic diseases. Their predictive software integrates medical imaging, clinical parameters, and patient history to forecast patient-specific risks such as aortic rupture or aneurysm formation. This AI-driven platform aims to assist cardiovascular surgeons in making informed treatment decisions, reducing uncertainty, improving patient outcomes, and standardizing care. Currently in development and not yet commercialized, Voythos is advancing its technology through partnerships and accelerator programs, positioning itself as a promising innovator in cardiovascular disease prediction and care.
Voythos
Voythos is a physician-founded bioinformatics startup developing multimodal artificial intelligence models to transform the management of aortic diseases. Their predictive software integrates medical imaging, clinical parameters, and patient history to forecast patient-specific risks such as aortic rupture or aneurysm formation. This AI-driven platform aims to assist cardiovascular surgeons in making informed treatment decisions, reducing uncertainty, improving patient outcomes, and standardizing care. Currently in development and not yet commercialized, Voythos is advancing its technology through partnerships and accelerator programs, positioning itself as a promising innovator in cardiovascular disease prediction and care.
TL;DR
Focus: Multimodal AI for predicting aortic and complex vascular disease outcomes
Stage: Early-stage / pre-commercial; in development and clinical validation
Founders: Joe Makoid (CEO) and Sophia Khan, MD (Co‑Founder & CMO)
Location: Houston, Texas
Company Overview
Problem Domain
Prediction and management of aortic and complex vascular disease
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
180000 USD
Early-stage financing with participation from institutional investors
Investor Signal
“Early-stage venture backing including Forum Ventures and Right Side Capital Management; participation in accelerator programs”